JMDSJournal of Medicines Development Sciences2382-63632382-6371WHIOCE PUBLISHING PTE. LTD.10.18063/jmds.v8i1.146ArticleA Case of Nonsteroidal Anti-Inflammatory Drug-Induced Anaphylaxis Confirmed by Skin Testinghttps://artdesignp.com/journal/JMDS/8/1/10.18063/jmds.v8i1.146LeeJaechun2023812023-08-25Nonsteroidal anti-inflammatory drugs (NSAIDs) are collectively a major culprit of drug-induced hypersensitivity. No reliable diagnostic tests, other than a direct challenge, are available for detecting the hypersensitivity. Cross-reactivity among NSAIDs that inhibit cyclooxygenase-1 is common. However, in rare cases, the mechanism underlying hypersensitivity can be understood from the immunological point of view, without involving cross-reactivity of NSAIDs or even with a positive skin test for an NSAID. A 55-year-old woman was referred to the Emergency Department for anaphylaxis. She suffered from generalized hives, chest tightness, and hypotension a few minutes after intramuscular injection of diclofenac. One year ago, she had experienced a similar reaction after intramuscular injection of aceclofenac. Thereafter, she had been taking naproxen as needed to relieve her osteoarthritis pain, without having an adverse reaction. To confirm drug hypersensitivity and to find alternative drugs, provocation tests were performed with acetaminophen, celecoxib, and lysine-aspirin. All tests were negative, and a skin prick test with diclofenac was also negative. However, intradermal injection of 0.05 mL (37.5 mg/mL) diclofenac provoked an anaphylactic shock and resulted in her admission. Here, we report a rare case of single NSAID-induced anaphylaxis, which was only triggered by acetic acid derivatives of NSAIDs, presumably by an immunoglobulin E-mediated reaction.

Kowalski ML, Makowska JS, 2015, Seven Steps to the Diagnosis of NSAIDs Hypersensitivity: How to Apply a New Classification in Real Practice? Allergy Asthma Immunol Res, 7: 312–320. FitzGerald GA, Patrono C, 2001, The Coxibs, Selective Inhibitors of Cyclooxygenase-2. New Engl J Med, 345: 433–442. Kowalski M, Asero R, Bavbek S, et al., 2013, Classification and Practical Approach to the Diagnosis and Management of Hypersensitivity to Nonsteroidal Anti‐Inflammatory Drugs. Allergy, 68: 1219–1232. Seong GM, Lee J, Kim C, 2020, Intravenous Aspirin Challenge as a Diagnosis of Nonsteroidal Anti-Inflammatory Drugs Hypersensitivity. Asian Pac J Allergy Immunol, 38: 124–128. Thong BYH, 2018, Nonsteroidal Anti-Inflammatory Drug Hypersensitivity in the Asia-Pacific. Asia Pac Allergy, 8: e38. Himly M, Jahn-Schmid B, Pittertschatscher K, et al., 2003, IgE-Mediated Immediate-Type Hypersensitivity to the Pyrazolone Drug Propyphenazone. J Allergy Clin Immunol, 111: 882–888. Harrer A, Lang R, Grims R, et al., 2010, Diclofenac Hypersensitivity: Antibody Responses to the Parent Drug and Relevant Metabolites. PLoS One, 5: e13707. Kim HS, Lee JH, Lee JY, et al., 2005, A Case of Diclofenac-Induced Anaphylaxis with Elevated Serum Tryptase. Korean J Asthma Allergy Clin Immunol, 25: 228–230. Lee JY, Byun YH, Cho YB, et al., 2005, Two Cases of Anaphylaxis to Diclofenac with Aspirin Tolerance. Korean J Med, 69: 113–116. Picaud J, Beaudouin E, Renaudin JM, et al., 2014, Anaphylaxis to Diclofenac: Nine Cases Reported to the Allergy Vigilance Network in France. Allergy, 69: 1420–1423. Brockow K, Garvey L, Aberer W, et al., 2013, ENDA/EAACI Drug Allergy Interest Group. Skin Test Concentrations for Systemically Administered Drugs – An ENDA/EAACI Drug Allergy Interest Group Position Paper. Allergy, 68: 702–712. Rojas‐Hijazo B, Garcés MM, Ferrer L, et al., 2006, Anaphylactic Reaction After Aceclofenac Intake. Allergy, 61: 511.